Oswal Pumps IPO to open on June 13: 10 things to know before subscribing

Oswal Pumps is set to open its initial public offering (IPO) for subscription from June 13 to June 17, 2025, aiming to raise Rs1,387.34 crore.The IPO comprises a fresh issue of 1.45 crore shares, aggregating to Rs 890 crore, and an offer for sale of 81 lakh shares, totalling Rs 497.34 crore. The shares are expected to be listed on the BSE and NSE, with a tentative listing date of June 20, 2025. advertisementThe IPO price band has been set between Rs 584 and Rs 614 per share, with a minimum application lot size of 24 shares.
Retail investors are required to invest a minimum of Rs 14,016, though bidding at the cutoff price is advised to mitigate the risk of oversubscription, which would amount to approximately Rs 14,736.On the other hand, the minimum investment for Small High Net-worth Individuals (sNII) is 14 lots (336 shares) at Rs 2,06,304, while for Big High Net-worth Individuals (bNII), it is 68 lots (1,632 shares) amounting to Rs 10,02,048. This structured approach ensures that various investor categories can participate according to their financial capabilities.Oswal Pumps Limited, incorporated in 2003, is a major player in the solar pump segment, providing products for domestic, agricultural, and industrial applications.advertisementThe company operates a manufacturing facility in Karnal, Haryana, covering over 41,000 square meters. As of August 31, 2024, Oswal Pumps completed 26,270 turnkey solar pumping systems under the PM-KUSUM Scheme across multiple Indian states.The IPO allotment is anticipated to be finalised on June 18, 2025.IIFL Capital Services Limited, Axis Capital Limited, and others are the book-running lead managers for this IPO, with MUFG Intime India Private Limited serving as the registrar.The last grey market premium for Oswal Pumps was Rs 67, suggesting a potential listing price of Rs 681 and an estimated gain of 10.91% per share.

Try Our AI Features

Explore what Daily8 AI can do for you:

Learn with AIFact CheckingText to SpeechAI Summary

Related Articles

News18

25 minutes ago

• News18

Indian Hockey Players To Get A Monthly Stipend From Sports Ministry

Last Updated: Indian hockey players selected for national camps will receive a Rs 25,000 monthly allowance. The decision, costing Rs 20 lakh per month, was approved by the sports ministry. For the first time, Indian hockey players selected for the men's and women's national camps will receive a Rs 25,000 monthly out-of-pocket allowance, a decision sanctioned by the sports ministry after consistent requests from the sport's governing body. Eighty players (40 men and 40 women) are set to benefit from this allowance, which is extended to athletes in the developmental group of the Target Olympic Podium Scheme. The decision was made during the Mission Olympic Cell's monthly meeting on Thursday. This allowance will cost the government Rs 20 lakh per month, while core group athletes receive Rs 50,000 per month. 'The allowance was being requested by Hockey India for some time, and we have decided to accept the demand. The players have performed reasonably well, and it is on merit," Sports Minister Mansukh Mandaviya informed reporters in an informal interaction. Hockey India will need to submit a list of players every month to facilitate the disbursement of funds. 'The list will consider form and fitness, and names might change depending on these factors," a sports ministry source explained. Currently, hockey players earn salaries from their respective departments and organisations, although a proposal for a graded contract system by Hockey India has been under consideration for the past few years. Their additional source of income comes from prize money for strong international performances in events like the Olympics and the Asian Games. The men's team has secured two consecutive bronze medals in the 2021 Tokyo Olympics and the subsequent Paris Games last year. The women's team finished fourth in Tokyo but did not qualify for the Paris event. Both teams are currently competing in the FIH Pro League's European leg, where the results have not been particularly encouraging so far. The MOC also approved financial proposals amounting to Rs 4.28 crore during the meeting. A significant portion of the funds — Rs 1.38 crore — will be allocated to tennis players such as Saketh Myneni, Jeevan Nedunchezhiyan, and three women players. 'Several proposals for assistance from para-athletes were also approved. Additionally, a few additions were made to the TOPS developmental group. The core group remains unchanged for now," a Sports Authority of India (SAI) official stated. The ministry has also decided to enhance its talent identification process with an app that will allow talented youngsters to upload their performances for evaluation by regional talent identification panels of the SAI. 'If found promising at first glance, the youngster will be invited to Khelo India Regional Centres where their potential will be assessed. This will broaden our talent identification mechanism, which is currently limited to age group competitions," Mandaviya said. 'It will ensure that we can reach the remotest corners of the country to find promising athletes. This is all part of the National Sports Repository System," he added. With PTI inputs.

Deccan Herald

37 minutes ago

• Deccan Herald

Samsung to launch Galaxy M36 5G next week in India

Thanks to deeper collaboration with Google and Samsung, the Galaxy M36 will support advanced versions of Gemini AI features. It will be priced under Rs 20,000 in India.

India.com

37 minutes ago

• India.com

Meet woman, daughter of India's richest pharma tycoon, she now leads Rs 3950000000000 company, she is…, her business is…

Vidhi Shanghvi, Sun Pharma Vidhi Shanghvi is daughter of Dilip Shanghvi, a famous Pharma businessman. She is in headlines for her role in Sun Pharma, one of India's biggest pharmaceutical companies. His net worth is around $25 billion and known as India's richest pharma billionaire. He is also among the top 100 richest people in the world. But now, his daughter Vidhi Shanghvi has also started handling his business. Who Is Vidhi Shanghvi? Vidhi Shanghvi is an Executive Director in Sun Pharma. After 13 years of experience, she now leads Sun Pharma's Consumer Healthcare and India Distribution. Sun Pharma was founded by her father, Dilip Shanghvi in 1983. They started making psychiatric drugs and slowly became India's most valuable pharma company, with a market capitalisation of Rs 3.95 lakh crore. Vidhi was recently appointed as Whole-time Director for a five-year term. Vidhi Shanghvi Educational Background Vidhi graduated from the Wharton School at the University of Pennsylvania. In Sun Pharma, she used her education in marketing and consumer healthcare. She began her career at Sun Pharma in 2012 as a Brand Manager in the India Business division. Over the years, she has held several leadership positions. In 2014, she became the Marketing Head for one of the company's Cardiovascular Business Units. She also handled many marketing campaigns. After the merger of Ranbaxy with Sun Pharma, Vidhi Shanghvi became the Business Head of the company's Consumer Healthcare Division. She has played a big role in the growth of the products like Revital H and Volini in retail stores, pharmacies, and online platforms in India. She also has expertise in various fields like marketing, brand building, project and alliance management, and distribution. She is the founder of Mann Talks, a not-for-profit mental health initiative. This platform gives free, holistic mental health solutions to individuals for their mental well-being.